158 related articles for article (PubMed ID: 33276756)
1. Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria.
Muhammad FM; Majdzadeh R; Nedjat S; Sajadi HS; Parsaeian M
BMC Public Health; 2020 Dec; 20(1):1860. PubMed ID: 33276756
[TBL] [Abstract][Full Text] [Related]
2. Decomposition of socioeconomic inequalities in the uptake of intermittent preventive treatment of malaria in pregnancy in Nigeria: evidence from Demographic Health Survey.
Okoli CI; Hajizadeh M; Rahman MM; Khanam R
Malar J; 2021 Jul; 20(1):300. PubMed ID: 34217299
[TBL] [Abstract][Full Text] [Related]
3. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
[TBL] [Abstract][Full Text] [Related]
6. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
[TBL] [Abstract][Full Text] [Related]
7. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
Azizi SC
BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
[TBL] [Abstract][Full Text] [Related]
8. Barriers to and determinants of the use of intermittent preventive treatment of malaria in pregnancy in Cross River State, Nigeria: a cross-sectional study.
Ameh S; Owoaje E; Oyo-Ita A; Kabiru CW; Akpet OEO; Etokidem A; Enembe O; Ekpenyong N
BMC Pregnancy Childbirth; 2016 May; 16():99. PubMed ID: 27147109
[TBL] [Abstract][Full Text] [Related]
9. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
[TBL] [Abstract][Full Text] [Related]
12. Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria.
Ndu A; Mbachu C; Anitube O; Ezeoke U
Malawi Med J; 2020 Mar; 32(1):45-51. PubMed ID: 32733659
[TBL] [Abstract][Full Text] [Related]
13. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
[TBL] [Abstract][Full Text] [Related]
15. Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria.
Adewole AO; Fawole O; Ajayi I; Yusuf B; Oladimeji A; Waziri E; Nguku P; Ajumobi O
Pan Afr Med J; 2019; 33():101. PubMed ID: 31489079
[TBL] [Abstract][Full Text] [Related]
16. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
[TBL] [Abstract][Full Text] [Related]
17. Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study.
Agyeman YN; Newton S; Annor RB; Owusu-Dabo E
PLoS One; 2021; 16(4):e0250350. PubMed ID: 33878140
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania.
Exavery A; Mbaruku G; Mbuyita S; Makemba A; Kinyonge IP; Kweka H
Malar J; 2014 Jan; 13():22. PubMed ID: 24423279
[TBL] [Abstract][Full Text] [Related]
19. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
20. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
Yaya S; Kota K; Buh A; Bishwajit G
BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
